About
Lipigon develops pharmaceutical treatments targeting elevated blood lipid levels, focusing on its clinical-stage drug Lipisense® which lowers triglycerides to reduce cardiovascular disease risk.
Explore Lipigon's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.